Headquartered in Medolla, Italy, Medica has over 700 employees globally and generated €80 million of revenue in 2023.
The company’s hollow fiber membrane filtration products are used for blood purification in applications including dialysis, continuous renal replacement therapies (CRRT), and therapeutic apheresis. Medica’s products and technologies are also used in the microbiological purification of water, as well as automation solutions for disposable medical device manufacturing.
“Hollow fiber membrane filtration is a fundamental filtration technology and Medica’s proprietary technology and expertise, along with their world-class manufacturing capabilities has enabled delivery of innovative, high-margin products to customers in several markets,” said Tod Carpenter, chairman, president and CEO of Donaldson.